문레이크 이뮤노테라퓨틱스 (MLTX)

MoonLake Immunotherapeutics (MLTX) 재무 분석

손익 계산서

분기별

*모든 숫자는 백만 단위입니다.

기간 종료일	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-09-30
기간	3개월	3개월	3개월	3개월	3개월
Revenues	-	-	-	-	-
Operating Expenses	15.81% 15.03	12.98	13.19	12.93	14.77
Operating Income/Loss	15.81% -15.03	-12.98	-13.19	-12.93	-14.77
Income/Loss From Continuing Operations Before Tax	32.33% -7.8431	-11.59	-12.35	-12.22	-14.73
Income Tax Expense/Benefit	53.19% 0.0443	0.0289	0.0101	0.011	0.00874
Income/Loss From Continuing Operations After Tax	32.12% -7.8874	-11.62	-12.35	-12.22	-14.74
Net Income/Loss	32.12% -7.8874	-11.62	-12.35	-12.22	-14.74
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	79.47% -0.4503	-2.1933	-2.2141	-3.2141	-4.6312
Basic Average Shares	93.20% 3.6369	53.52	43.72	39.06	36.93
Diluted Average Shares	93.20% 3.6369	53.52	43.72	39.06	36.93
Basic Earnings Per Share	44.44% -0.10	-0.18	-0.23	-0.23	-0.27
Diluted Earnings Per Share	44.44% -0.10	-0.18	-0.23	-0.23	-0.27
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-